Advanced Drug Delivery Systems Market
Advanced drug delivery systems Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025
Advanced Drug Delivery Systems Market Segmented By Delivery mode that is Oral drug delivery, Pulmonary drug delivery, Transdermal drug delivery, Parenteral drug delivery, also by Carrier Type that is Liposomes, Nanoparticles, Microspheres, Monoclonal antibodies used in Hospitals, Specialized clinics, Clinical Research & Development Centers.
Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted delivery for onsite drug release and absorption are the basis for the development of advanced drug delivery systems.
Furthermore, the development of improved methods of drug delivery is preferred these days over the search for novel molecules. There are various dosage forms available by which a drug substance can be incorporated for efficacious delivery. Advancements in biotechnology and nanotechnology have significantly boosted the development of novel drug delivery approaches.
Various interdisciplinary studies in the field of polymer science, pharmaceuticals, organic chemistry and molecular biology are required for the development of advanced drug delivery systems. The drug delivery system comprise of drug formulation, dosage form and mechanism of release.
These advanced delivery systems have the potential of overcoming one of the major problem faced by the pharmaceutical industry for the onsite drug efficacy. Development of advanced drug delivery systems needs into consideration several factors such as pharmacodynamics, drug toxicity, immunogenicity, bio compatibility, pharmacokinetics as well as drug efficacy.
Most of the advanced drug delivery systems are developed keeping in mind the cancer treatment as the chemotherapy drugs needs to have deeper penetration into the cancer site as well avoiding various associated side effects.
Find Out More about the Report Coverage
Advanced drug delivery systems market: Drivers & Restraints
Various advantages of advanced drug delivery systems over the conventional delivery systems such as on site action, reduce dosing amount, increased drug efficacy, therapeutic success rate etc. support its market growth. In addition, increasing clinical research activities in the development of more advanced drug delivery systems would also be fuelling the market growth.
Certain technical limitations in the development of methods, stringent regulations, high pricing for the advanced products, non-availability in the low income countries are some of the factors limiting the market growth of global advanced drug delivery systems.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
|By Delivery Mode||
|By Carrier Type||
|By End Users||
Development of novel drug delivery systems is dependent on the number of funding projects for its research and development. The price of the delivery system depends on the complexity of disease, drug molecule and the delivery mode preferred. Market growth is also dependent on the adoption rate of these advanced delivery systems by healthcare practitioners.
Various advanced drug delivery and drug targeting systems are currently under development which may fuel the market in future. Emergence of new bioactive materials and gene therapy are also getting attention for the development of advanced drug delivery systems. The collaborations and mergers by the industry players also have a significant impact on the market for advanced drug delivery systems.
Geographically, the market for advanced drug delivery systems can be segmented into five regions, North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America dominates the global advanced drug delivery systems market owing to the better adoption of improved drug delivery solutions as well as follow up of advanced treatment approaches in healthcare.
This is followed by the European market owing to better healthcare infrastructure facilities and growing number of research activities in the healthcare domain over the region. Asia Pacific region represents significant market opportunities in the advanced drug delivery systems due to the improvement in healthcare infrastructure as well as increasing healthcare spending and rising disease prevalence. Latin America followed by MEA represents the lowest market share as well as growth rate in the advanced drug delivery solution with the lower adoption rate over the region.
Some major key players of advanced drug delivery systems market include NeXstar Pharmaceuticals, Inc., West Pharmaceutical Services, Inc., AstraZeneca, Sequus Pharmaceuticals Inc., 3M, Novartis International AG and others.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
The report covers exhaustive analysis on:
- Advanced drug delivery systems Market Segments
- Advanced drug delivery systems Market Dynamics
- Advanced drug delivery systems Historical Market Size
- Advanced drug delivery systems Market Size & Forecast
- Advanced drug delivery systems Market Current Trends/Issues/Challenges
- Advanced drug delivery systems Competition & Companies involved
- Advanced drug delivery systems Market Drivers and Restraints
Explore Persistence Market Research’s expertise in promulgation of the business !
Regional analysis includes:
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance